Apyx Medical (APYX) Competitors $1.90 -0.06 (-3.06%) Closing price 07/30/2025 04:00 PM EasternExtended Trading$1.91 +0.01 (+0.53%) As of 07/30/2025 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock APYX vs. TMCI, OM, SNWV, RXST, CLPT, CATX, NNOX, STIM, NPCE, and DRTSShould you be buying Apyx Medical stock or one of its competitors? The main competitors of Apyx Medical include Treace Medical Concepts (TMCI), Outset Medical (OM), Sanuwave Health (SNWV), RxSight (RXST), ClearPoint Neuro (CLPT), Perspective Therapeutics (CATX), Nano-X Imaging (NNOX), Neuronetics (STIM), NeuroPace (NPCE), and Alpha Tau Medical (DRTS). These companies are all part of the "medical equipment" industry. Apyx Medical vs. Its Competitors Treace Medical Concepts Outset Medical Sanuwave Health RxSight ClearPoint Neuro Perspective Therapeutics Nano-X Imaging Neuronetics NeuroPace Alpha Tau Medical Treace Medical Concepts (NASDAQ:TMCI) and Apyx Medical (NASDAQ:APYX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, analyst recommendations, media sentiment, earnings, dividends and profitability. Do analysts recommend TMCI or APYX? Treace Medical Concepts presently has a consensus target price of $10.52, suggesting a potential upside of 89.83%. Given Treace Medical Concepts' higher probable upside, research analysts clearly believe Treace Medical Concepts is more favorable than Apyx Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Treace Medical Concepts 0 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33Apyx Medical 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.67 Which has more volatility & risk, TMCI or APYX? Treace Medical Concepts has a beta of 0.69, indicating that its share price is 31% less volatile than the S&P 500. Comparatively, Apyx Medical has a beta of 1.31, indicating that its share price is 31% more volatile than the S&P 500. Which has better valuation & earnings, TMCI or APYX? Apyx Medical has lower revenue, but higher earnings than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Apyx Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTreace Medical Concepts$209.36M1.66-$55.74M-$0.85-6.52Apyx Medical$48.10M1.49-$23.46M-$0.55-3.45 Is TMCI or APYX more profitable? Treace Medical Concepts has a net margin of -25.14% compared to Apyx Medical's net margin of -42.37%. Treace Medical Concepts' return on equity of -48.69% beat Apyx Medical's return on equity.Company Net Margins Return on Equity Return on Assets Treace Medical Concepts-25.14% -48.69% -24.59% Apyx Medical -42.37%-156.85%-31.92% Does the media refer more to TMCI or APYX? In the previous week, Treace Medical Concepts and Treace Medical Concepts both had 3 articles in the media. Treace Medical Concepts' average media sentiment score of 1.82 beat Apyx Medical's score of 0.63 indicating that Treace Medical Concepts is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Treace Medical Concepts 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Apyx Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals believe in TMCI or APYX? 84.1% of Treace Medical Concepts shares are held by institutional investors. Comparatively, 55.3% of Apyx Medical shares are held by institutional investors. 27.7% of Treace Medical Concepts shares are held by insiders. Comparatively, 15.2% of Apyx Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. SummaryTreace Medical Concepts beats Apyx Medical on 10 of the 16 factors compared between the two stocks. Get Apyx Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for APYX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding APYX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APYX vs. The Competition Export to ExcelMetricApyx MedicalMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$74.08M$10.67B$5.63B$9.53BDividend YieldN/A1.92%4.71%4.04%P/E Ratio-3.4517.8830.2020.54Price / Sales1.4929.04455.8798.78Price / CashN/A23.1436.0158.40Price / Book5.003.598.345.74Net Income-$23.46M$234.77M$3.25B$259.12M7 Day Performance-19.83%-1.96%-2.15%-2.68%1 Month Performance-15.56%3.96%7.97%8.53%1 Year Performance39.71%-14.42%36.49%14.91% Apyx Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APYXApyx Medical1.9007 of 5 stars$1.90-3.1%N/A+40.7%$74.08M$48.10M-3.45270News CoverageUpcoming EarningsTMCITreace Medical Concepts2.7878 of 5 stars$5.75+0.9%$10.52+82.9%-25.5%$358.47M$209.36M-6.76250Positive NewsOMOutset Medical1.2887 of 5 stars$18.04-2.6%$29.50+63.5%-67.9%$328.39M$115.27M-0.62520News CoverageUpcoming EarningsSNWVSanuwave Health1.9996 of 5 stars$35.75-5.6%N/AN/A$324.43M$32.63M-7.8540News CoverageAnalyst ForecastGap UpRXSTRxSight2.5655 of 5 stars$7.87-1.3%$17.50+122.4%-82.3%$323.88M$139.93M-11.75220Trending NewsUpcoming EarningsCLPTClearPoint Neuro2.2529 of 5 stars$10.97-2.3%$25.00+127.9%+47.9%$314.32M$31.39M-14.43110Positive NewsCATXPerspective Therapeutics2.3209 of 5 stars$4.12+1.5%$12.56+204.7%-69.1%$305.82MN/A0.0070NNOXNano-X Imaging2.0604 of 5 stars$5.14-1.2%$9.50+84.8%-44.5%$300.45M$11.55M-5.71190Positive NewsSTIMNeuronetics1.5384 of 5 stars$4.52+0.7%$5.50+21.7%+141.3%$296.85M$74.89M-3.45180News CoveragePositive NewsUpcoming EarningsNPCENeuroPace3.3886 of 5 stars$8.74-2.7%$17.00+94.5%+13.8%$294.53M$79.91M-10.40170News CoveragePositive NewsDRTSAlpha Tau Medical3.0887 of 5 stars$3.00-2.0%$8.00+166.7%+31.8%$259.55MN/A-6.5280Positive News Related Companies and Tools Related Companies TMCI Competitors OM Competitors SNWV Competitors RXST Competitors CLPT Competitors CATX Competitors NNOX Competitors STIM Competitors NPCE Competitors DRTS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:APYX) was last updated on 7/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apyx Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Apyx Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free APYX Stock Alerts